about
The Ratio of Regulatory (FOXP3+) to Total (CD3+) T Cells Determined by Epigenetic Cell Counting and Cardiovascular Disease Risk: A Prospective Case-cohort Study in Non-diabeticsPhysical activity and risk of Amyotrophic Lateral Sclerosis in a prospective cohort studyCommon germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumorsFruit and vegetable intake and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).Plasma 25-hydroxyvitamin D and its genetic determinants in relation to incident myocardial infarction and stroke in the European prospective investigation into cancer and nutrition (EPIC)-Germany studyThe improved physical activity index for measuring physical activity in EPIC GermanyPre-diagnostic concordance with the WCRF/AICR guidelines and survival in European colorectal cancer patients: a cohort study.Urinary excretions of 34 dietary polyphenols and their associations with lifestyle factors in the EPIC cohort study.Flavonoid and lignan intake and pancreatic cancer risk in the European prospective investigation into cancer and nutrition cohort.Association of Multiple Biomarkers of Iron Metabolism and Type 2 Diabetes: The EPIC-InterAct Study.The association between dietary flavonoid and lignan intakes and incident type 2 diabetes in European populations: the EPIC-InterAct study.Circulating vitamin D in relation to cancer incidence and survival of the head and neck and oesophagus in the EPIC cohort.Dietary intakes of individual flavanols and flavonols are inversely associated with incident type 2 diabetes in European populations.Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer riskEvaluation of urinary resveratrol as a biomarker of dietary resveratrol intake in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.Consumption of Fish Is Not Associated with Risk of Differentiated Thyroid Carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study.Pre-diagnostic copper and zinc biomarkers and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort.Obesity and Breast Cancer.Changes in Waist Circumference among German Adults over Time - Compiling Results of Seven Prospective Cohort Studies.Pre-diagnostic meat and fibre intakes in relation to colorectal cancer survival in the European Prospective Investigation into Cancer and Nutrition.Socioeconomic status and anthropometric changes-A meta-analytic approach from seven German cohorts.Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation.Albumin, bilirubin, uric acid and cancer risk: results from a prospective population-based study.Lack of Association for Reported Endocrine Pancreatic Cancer Risk Loci in the PANDoRA Consortium.Biological reproducibility of circulating P-Selectin, Thrombopoietin, GPIIb/IIIa and Thrombomodulin over one year.Pre-diagnostic polyphenol intake and breast cancer survival: the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.Meat and haem iron intake in relation to glioma in the European Prospective Investigation into Cancer and Nutrition study.Parkinson's Disease Case Ascertainment in the EPIC Cohort: The NeuroEPIC4PD Study.Prediagnostic selenium status and hepatobiliary cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort.Prevalence and Progression of Lower Urinary Tract Symptoms in an Aging Population.Body iron status and gastric cancer risk in the EURGAST study.Dietary fat, fat subtypes and hepatocellular carcinoma in a large European cohort.Subtypes of fruit and vegetables, variety in consumption and risk of colon and rectal cancer in the European Prospective Investigation into Cancer and Nutrition.Erratum. Dietary protein intake and incidence of type 2 diabetes in europe: the EPIC-InterAct case-cohort study. Diabetes Care 2014;37:1854-1862.
P50
Q28277713-7D6F4F2A-87C4-4EDC-A604-184C308E43C7Q28391291-A6719DBC-FC12-4D1C-9C98-D594A36E30C7Q28397098-FFBB0344-2A41-4D0D-9E6B-F0EE70696663Q33845683-3B1F5BF9-A953-431C-888A-91801BFF2AD4Q34919132-B5EB0B7D-13F1-4AF8-897F-A8DEF405624CQ35124083-6C84D435-1332-42FB-86DA-1C2F488E3840Q35579079-8DF65BF0-6A3D-4783-AA7B-6537C1B6D5C9Q36974523-E02495DE-E431-4BBA-98C2-B0DAD28FF503Q37105257-1E1E8DDB-479C-4025-B8EA-6AF90211E637Q37327008-DD3E0D79-517D-4B38-B26A-9D1220A623D7Q37331353-A0AD9E46-B963-4B09-A1D5-7808A0905553Q37394011-5FF72180-210D-4999-BD75-39B2CD00EF06Q37590374-CDE1607A-7787-4776-9CCF-8DE7CA80B6FFQ37636741-523B0F32-1E92-4C43-A053-088CF5BD18ABQ38715207-9A6995FA-96CF-4FA5-93E2-EB84C019502DQ38737602-FE606AC7-7397-48F0-B7B6-82F79B02F717Q38748363-43CC5EFB-06D0-48A5-B714-18CD06C7A4FBQ39026644-DFCD9968-1BDA-4A37-B76A-8F9EBF4F4EBFQ39324736-0179BE94-A263-4F99-B4AE-196DA8672FA5Q39755745-A4D0C892-E3BA-476F-9AB2-56ADB4F27203Q40034655-3EDA1876-C7CA-49BB-AF15-8D97E8D116AFQ40039447-B5972449-CA7E-4B25-8FCD-1F9CCFA4CE1FQ40045667-007A5A27-0C4D-4ED6-990E-BDF07ABE1658Q40098817-1ACC0B80-4BB7-4BF4-B569-5911678E5B75Q40177097-6A6790EE-182B-4681-9445-A7BBA9F4FCACQ40359289-B25DD6BE-8020-43FC-90DB-222B66881208Q40475158-0873F940-8F2C-484C-AA0B-81D95CEB2446Q40534014-62E9D907-3CFF-4BCC-A2E0-7CDD03EEEFFDQ40675361-17D5D113-387F-4A7F-8345-3B9BB1D06244Q40680845-EA8BB4D7-4140-4F0F-898D-238AF2EF5176Q41620807-5796933B-88AF-48DC-8A84-692343B874E1Q41664327-910BFACA-A06C-43DA-8C45-D5206DF6706CQ41667667-8416D48E-3721-4315-845A-5E19325BE94EQ42320386-FACAFDA0-99A3-4751-870C-AF076B793631
P50
description
onderzoeker
@nl
name
Verena Katzke
@ast
Verena Katzke
@en
Verena Katzke
@es
Verena Katzke
@nl
Verena Katzke
@sl
type
label
Verena Katzke
@ast
Verena Katzke
@en
Verena Katzke
@es
Verena Katzke
@nl
Verena Katzke
@sl
prefLabel
Verena Katzke
@ast
Verena Katzke
@en
Verena Katzke
@es
Verena Katzke
@nl
Verena Katzke
@sl
P214
P106
P21
P213
0000 0003 7542 9672
P214
P31
P735
P7859
viaf-251936295